A letter signed by 76 doctors in the UK has been sent to the Medical and Healthcare products Regulatory Agency (MHRA) and other U.K. Government officials.
- The letter lays out comprehensive reasons why the recent U.S. FDA decision authorizing COVID vaccinations in infants and young children must not happen in the United Kingdom.
- It is noteworthy that Sweden and Norway are not recommending the vaccine for 5-11s and Holland is not recommending it for children who have already had COVID-19.
Extremely low risk from COVID-19 to young children
- Children clear the virus more easily than adults
- Since the arrival of the Omicron variant, infections have been generally much milder
- Recent data from Israel show excellent long-lasting immunity following infection in children, especially in 5-11s
Poor vaccine efficacy
- Adult: vaccine efficacy wanes steadily over time, necessitating boosters at regular intervals.
- In children, vaccine efficacy has waned more rapidly in 5-11s than in 12-17s, possibly related to the lower dose used in the pediatric formulation.
Potential harms of COVID-19 vaccines for children
- 50% of vaccinated children had systemic adverse events, including irritability and fever.
- The emerging evidence of cardiac abnormalities in adolescents with post-mRNA vaccine myopericarditis, as demonstrated by cardiac MRI at 3-8 months follow up, suggests this is far from "mild and short-lived".
- Potential for longer term effects require further study and calls for the strictest application of the precautionary principle in respect of the youngest and most vulnerable children.
Informed consent
- For 5-11s, the JCVI specifically noted the importance of fully informed consent with no coercion.
- The complete omission of information explaining to the public the different and novel technology used in COVID-19 vaccines compared to standard vaccines, and the failure to inform of the lack of any long-term safety data, borders on misinformation.
Effect on public confidence
- Vaccines against much more serious diseases, such as polio and measles, need to be prioritized
- Pushing an unnecessary and novel, gene-based vaccine on to young children risks seriously undermining parental confidence in the whole immunization program
- The poor quality of the data presented by Pfizer risks bringing the pharmaceutical industry into disrepute and the regulators if this product is authorized
https://brownstone.org/articles/letter-to-the-u-k-gov-from-76-doctors/
No comments:
Post a Comment